Elevance Health (ELV) Q1 2026 Earnings
Elevance Health reported Q1 2026 revenue of $49.5B, beat analyst consensus of $48.2B by $1.3B. Diluted EPS came in at $12.58, beat the $11.03 consensus by $1.55. Elevance Health reports across 3 business segments, led by Health Benefits, CarelonRx, and Carelon Services.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Elevance Health's Q1 2026 earnings report.
Elevance Health (ELV) reported Q1 2026 earnings on April 22, 2026 before market open.
Elevance Health reported revenue of $49.5B and diluted EPS of $12.58 for Q1 2026.
Revenue beat the consensus estimate of $48.2B by $1.3B. EPS beat the consensus estimate of $11.03 by $1.55.
You can read the 8-K earnings release (0001156039-26-000039) and the 10-Q periodic report (0001156039-26-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.